News: New Triple-Action CRISPR Technology Enables Simultaneous Gene Activation, Repression, and Deletion in Primary Human T Cells

Scientists have developed a method that allows for simultaneous activation, repression, and knockout of genes within a single cell. By leveraging orthogonal CRISPR/Cas systems, the team has demonstrated the potential of advanced CRISPR technologies for innovative applications in gene therapy and regenerative medicine.